Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Sustained antidiabetic effects of a berberine-containing Chinese herbal medicine through regulation of hepatic gene expression.

Zhao HL, Sui Y, Qiao CF, Yip KY, Leung RK, Tsui SK, Lee HM, Wong HK, Zhu X, Siu JJ, He L, Guan J, Liu LZ, Xu HX, Tong PC, Chan JC.

Diabetes. 2012 Apr;61(4):933-43. doi: 10.2337/db11-1164. Epub 2012 Mar 6.

2.

Metabolomics Study of Type 2 Diabetes Mellitus and the AntiDiabetic Effect of Berberine in Zucker Diabetic Fatty Rats Using Uplc-ESI-Hdms.

Dong Y, Chen YT, Yang YX, Zhou XJ, Dai SJ, Tong JF, Shou D, Li C.

Phytother Res. 2016 May;30(5):823-8. doi: 10.1002/ptr.5587. Epub 2016 Feb 16.

PMID:
26888689
3.

Berberine acutely inhibits the digestion of maltose in the intestine.

Li ZQ, Zuo DY, Qie XD, Qi H, Zhao MQ, Wu YL.

J Ethnopharmacol. 2012 Jul 13;142(2):474-80. doi: 10.1016/j.jep.2012.05.022. Epub 2012 May 22.

PMID:
22626925
4.

The anti-diabetic effects and pharmacokinetic profiles of berberine in mice treated with Jiao-Tai-Wan and its compatibility.

Chen G, Lu F, Xu L, Dong H, Yi P, Wang F, Huang Z, Zou X.

Phytomedicine. 2013 Jul 15;20(10):780-6. doi: 10.1016/j.phymed.2013.03.004. Epub 2013 Apr 10.

PMID:
23582408
5.
6.

Sodium caprate augments the hypoglycemic effect of berberine via AMPK in inhibiting hepatic gluconeogenesis.

Zhang M, Lv X, Li J, Meng Z, Wang Q, Chang W, Li W, Chen L, Liu Y.

Mol Cell Endocrinol. 2012 Nov 5;363(1-2):122-30. doi: 10.1016/j.mce.2012.08.006. Epub 2012 Aug 16.

7.

Berberine reducing insulin resistance by up-regulating IRS-2 mRNA expression in nonalcoholic fatty liver disease (NAFLD) rat liver.

Xing LJ, Zhang L, Liu T, Hua YQ, Zheng PY, Ji G.

Eur J Pharmacol. 2011 Oct 15;668(3):467-71. doi: 10.1016/j.ejphar.2011.07.036. Epub 2011 Aug 4.

PMID:
21839075
8.

Protective effect of berberine on antioxidant enzymes and positive transcription elongation factor b expression in diabetic rat liver.

Zhou JY, Zhou SW.

Fitoterapia. 2011 Mar;82(2):184-9. doi: 10.1016/j.fitote.2010.08.019. Epub 2010 Sep 7.

PMID:
20828602
9.

Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states.

Lee YS, Kim WS, Kim KH, Yoon MJ, Cho HJ, Shen Y, Ye JM, Lee CH, Oh WK, Kim CT, Hohnen-Behrens C, Gosby A, Kraegen EW, James DE, Kim JB.

Diabetes. 2006 Aug;55(8):2256-64.

10.

Berberine inhibits hepatic gluconeogenesis via the LKB1-AMPK-TORC2 signaling pathway in streptozotocin-induced diabetic rats.

Jiang SJ, Dong H, Li JB, Xu LJ, Zou X, Wang KF, Lu FE, Yi P.

World J Gastroenterol. 2015 Jul 7;21(25):7777-85. doi: 10.3748/wjg.v21.i25.7777.

11.

Berberine reduces ischemia/reperfusion-induced myocardial apoptosis via activating AMPK and PI3K-Akt signaling in diabetic rats.

Chen K, Li G, Geng F, Zhang Z, Li J, Yang M, Dong L, Gao F.

Apoptosis. 2014 Jun;19(6):946-57. doi: 10.1007/s10495-014-0977-0.

PMID:
24664781
12.

Antihyperglycemic effect of the traditional Chinese scutellaria-coptis herb couple and its main components in streptozotocin-induced diabetic rats.

Liu SZ, Deng YX, Chen B, Zhang XJ, Shi QZ, Qiu XM.

J Ethnopharmacol. 2013 Jan 30;145(2):490-8. doi: 10.1016/j.jep.2012.11.017. Epub 2012 Nov 23.

PMID:
23183087
13.

Traditional chinese medicine in treatment of metabolic syndrome.

Yin J, Zhang H, Ye J.

Endocr Metab Immune Disord Drug Targets. 2008 Jun;8(2):99-111. Review.

14.

Modulating gut microbiota as an anti-diabetic mechanism of berberine.

Han J, Lin H, Huang W.

Med Sci Monit. 2011 Jul;17(7):RA164-7. Review.

15.

Advances in structural modifications and biological activities of berberine: an active compound in traditional Chinese medicine.

Huang ZJ, Zeng Y, Lan P, Sun PH, Chen WM.

Mini Rev Med Chem. 2011 Nov;11(13):1122-9. Review.

PMID:
22353221
16.

Berberine regulated Gck, G6pc, Pck1 and Srebp-1c expression and activated AMP-activated protein kinase in primary rat hepatocytes.

Ge Y, Zhang Y, Li R, Chen W, Li Y, Chen G.

Int J Biol Sci. 2011;7(5):673-84. Epub 2011 May 24.

17.

Attenuation of diabetic nephropathy by Chaihuang-Yishen granule through anti-inflammatory mechanism in streptozotocin-induced rat model of diabetics.

Zhang H, Zhao T, Gong Y, Dong X, Zhang W, Sun S, Wang H, Gu Y, Lu X, Yan M, Li P.

J Ethnopharmacol. 2014;151(1):556-64. doi: 10.1016/j.jep.2013.11.020. Epub 2013 Nov 22.

PMID:
24269779
18.

Berberine treatment prevents cardiac dysfunction and remodeling through activation of 5'-adenosine monophosphate-activated protein kinase in type 2 diabetic rats and in palmitate-induced hypertrophic H9c2 cells.

Chang W, Zhang M, Meng Z, Yu Y, Yao F, Hatch GM, Chen L.

Eur J Pharmacol. 2015 Dec 15;769:55-63. doi: 10.1016/j.ejphar.2015.10.043. Epub 2015 Oct 30.

PMID:
26522928
19.

Berberine inhibits mouse insulin gene promoter through activation of AMP activated protein kinase and may exert beneficial effect on pancreatic β-cell.

Shen N, Huan Y, Shen ZF.

Eur J Pharmacol. 2012 Nov 5;694(1-3):120-6. doi: 10.1016/j.ejphar.2012.07.052. Epub 2012 Aug 29.

PMID:
22955013
20.

Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity.

Kim WS, Lee YS, Cha SH, Jeong HW, Choe SS, Lee MR, Oh GT, Park HS, Lee KU, Lane MD, Kim JB.

Am J Physiol Endocrinol Metab. 2009 Apr;296(4):E812-9. doi: 10.1152/ajpendo.90710.2008. Epub 2009 Jan 27.

PMID:
19176354

Supplemental Content

Support Center